衰老细胞清除药物可逆转阻塞性睡眠呼吸暂停小鼠模型的终末器官功能障碍
该研究在慢性间歇性缺氧小鼠模型中,比较了部分常氧恢复单用或联合衰老细胞清除药物navitoclax治疗6周对心脏代谢和神经认知参数的影响。结果显示,仅联合navitoclax时,部分常氧恢复才显著改善嗜睡、认知、冠状动脉功能、糖脂代谢,并降低肠道通透性和多器官衰老。结论提示,OSA终末器官病变的可逆性不仅取决于恢复正常氧合模式,还可通过靶向衰老等有害细胞过程进一步增强。
要点
- 在OSA小鼠模型中,部分常氧恢复联合navitoclax可显著改善嗜睡和认知。
- 联合治疗还改善冠状动脉功能、糖脂代谢并降低肠道通透性和多器官衰老。
- 单独部分常氧恢复对上述终末器官结局的改善作用有限。
核心结论
- OSA诱导的终末器官病变可逆性不仅依赖于恢复正常氧合模式,还可通过靶向衰老等有害细胞过程进一步增强。
研究设计与样本
- 研究为小鼠慢性间歇性缺氧模型,比较16周间歇性缺氧暴露后6周部分常氧恢复单用或联合衰老细胞清除药物navitoclax对多表型心脏代谢和神经认知参数的影响。
主要发现
- 仅联合navitoclax时,部分常氧恢复显著改善嗜睡(黑暗期睡眠:34%±4% vs. 26%±3%;P<0.01)。
- 联合治疗显著改善认知(偏好评分:51%±19% vs. 70%±11%;P=0.048)。
- 联合治疗显著改善冠状动脉功能(对乙酰胆碱的血管舒张反应:56%±13% vs. 72%±10%;P<0.001)。
- 联合治疗还改善糖脂代谢,并降低肠道通透性和多器官衰老。
临床怎么用
- 在OSA患者中,除恢复氧合外,靶向衰老等细胞过程可能作为辅助治疗策略改善终末器官结局,但需临床研究验证。
局限性
- 研究为小鼠模型,结果不能直接外推至人类OSA患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Obstructive sleep apnea (OSA) is a highly prevalent condition that is associated with accelerated biological aging and multiple end-organ morbidities. Current treatments, such as continuous positive airway pressure (CPAP), have shown limited cognitive, metabolic, and cardiovascular beneficial outcomes despite adherence. Thus, adjunct therapies aiming to reduce OSA burden, such as senolytics, could improve OSA outcomes.Objectives: To assess if targeting senescence in addition to partial normoxia mimicking "good" CPAP adherence can improve physiological outcomes in mice exposed to chronic intermittent hypoxia.Methods: We compared the effects of 6 weeks of therapy with either partial normoxic recovery alone or combined with the senolytic navitoclax after 16 weeks of intermittent hypoxia exposures, a hallmark of OSA, on multiphenotypic cardiometabolic and neurocognitive parameters.Measurements and Main Results: Our findings indicate that only when combined with navitoclax, partial normoxic recovery significantly improved sleepiness (sleep in the dark phase: 34% ± 4% vs. 26% ± 3%; P < 0.01), cognition (preference score: 51% ± 19% vs. 70% ± 11%; P = 0.048), coronary artery function (response to acetylcholine [vasodilation]: 56% ± 13% vs. 72% ± 10%; P < 0.001), glucose, and lipid metabolism and reduced intestinal permeability and senescence in multiple organs.Conclusions: These findings indicate that the reversibility of end-organ morbidities induced by OSA is not only contingent on restoration of normal oxygenation patterns but can be further enhanced by targeting other OSA-mediated detrimental cellular processes, such as accelerated senescence.
引用
- Badran M, Puech C, Khalyfa A, et al. Senolytic-facilitated Reversal of End-Organ Dysfunction in a Murine Model of Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2024. PMID: 38113165. doi:10.1164/rccm.202306-1101OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。